FI962324A0 - N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF - Google Patents
N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASFInfo
- Publication number
- FI962324A0 FI962324A0 FI962324A FI962324A FI962324A0 FI 962324 A0 FI962324 A0 FI 962324A0 FI 962324 A FI962324 A FI 962324A FI 962324 A FI962324 A FI 962324A FI 962324 A0 FI962324 A0 FI 962324A0
- Authority
- FI
- Finland
- Prior art keywords
- neuroleptic
- asf
- pct
- azabicycloalkane derivatives
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Ink Jet (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4341403A DE4341403A1 (de) | 1993-12-04 | 1993-12-04 | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
PCT/EP1994/003913 WO1995015327A1 (en) | 1993-12-04 | 1994-11-26 | N-substituted azabicycloalkane derivatives as neuroleptika asf |
Publications (3)
Publication Number | Publication Date |
---|---|
FI962324A FI962324A (fi) | 1996-06-03 |
FI962324A0 true FI962324A0 (fi) | 1996-06-03 |
FI113644B FI113644B (fi) | 2004-05-31 |
Family
ID=6504205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI962324A FI113644B (fi) | 1993-12-04 | 1996-06-03 | Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi |
Country Status (13)
Country | Link |
---|---|
US (1) | US5703091A (fi) |
EP (1) | EP0731802B1 (fi) |
JP (1) | JP3935201B2 (fi) |
AT (1) | ATE194620T1 (fi) |
AU (1) | AU680583B2 (fi) |
BR (1) | BR9408246A (fi) |
DE (2) | DE4341403A1 (fi) |
ES (1) | ES2148476T3 (fi) |
FI (1) | FI113644B (fi) |
IL (1) | IL111861A (fi) |
NO (1) | NO306346B1 (fi) |
TW (1) | TW285667B (fi) |
WO (1) | WO1995015327A1 (fi) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19848521A1 (de) * | 1998-10-21 | 2000-04-27 | Basf Ag | Verfahren zur Herstellung von (+)-exo-6-Phenyl-3-azabicyclo-[3.2.0]heptanen |
DE19854147A1 (de) * | 1998-11-24 | 2000-05-25 | Basf Ag | Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht |
TWI244481B (en) | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
CA2386049A1 (en) | 1999-10-15 | 2001-04-26 | Daniel S. Gardner | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
US6784200B2 (en) * | 2000-10-13 | 2004-08-31 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
GB0015562D0 (en) * | 2000-06-23 | 2000-08-16 | Pfizer Ltd | Heterocycles |
SE0100326D0 (sv) | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
BR0207952A (pt) * | 2001-03-07 | 2004-07-27 | Pfizer Prod Inc | Moduladores da atividade de receptores de quimiocina |
WO2004016604A2 (en) * | 2002-08-14 | 2004-02-26 | Abbott Laboratories | Azabicyclic compounds are central nervous system active agents |
EP1534675B1 (en) | 2002-08-23 | 2009-02-25 | Ranbaxy Laboratories, Ltd. | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists |
EP2177511A2 (en) * | 2002-12-10 | 2010-04-21 | Ranbaxy Laboratories Limited | Process for preparing 3,6-disubstituted azabicyclo derivatives |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
MXPA06014404A (es) | 2004-06-09 | 2007-02-19 | Hoffmann La Roche | Compuestos heterociclicos antivirales. |
GB0507602D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
US7665658B2 (en) | 2005-06-07 | 2010-02-23 | First Data Corporation | Dynamic aggregation of payment transactions |
EP1849771A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP1849772A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP2029536B1 (en) | 2006-04-28 | 2013-08-28 | Laboratorios Del. Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
GB0625198D0 (en) * | 2006-12-18 | 2007-01-24 | Glaxo Group Ltd | Chemical compounds |
GB0809479D0 (en) * | 2008-05-23 | 2008-07-02 | Glaxo Group Ltd | Novel compounds |
EP2595989B1 (en) | 2010-05-06 | 2016-07-13 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
EP2621902B1 (en) * | 2010-09-28 | 2017-04-12 | Panacea Biotec Ltd | 3-azabicyclo[3.1.0]hexane compounds useful for the treatment of cns disorders |
WO2012071369A2 (en) | 2010-11-24 | 2012-05-31 | The Trustees Of Columbia University In The City Of New York | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
EP2670752B1 (en) | 2011-02-02 | 2016-03-16 | Vertex Pharmaceuticals Incorporated | Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels |
WO2012112743A1 (en) | 2011-02-18 | 2012-08-23 | Vertex Pharmaceuticals Incorporated | Chroman - spirocyclic piperidine amides as modulators of ion channels |
US8828996B2 (en) | 2011-03-14 | 2014-09-09 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
US9333202B2 (en) | 2012-05-01 | 2016-05-10 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease |
ES2700541T3 (es) | 2013-03-14 | 2019-02-18 | Univ Columbia | Octahidrociclopentapirroles, su preparación y uso |
WO2014151936A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles, their preparation and use |
US9938291B2 (en) | 2013-03-14 | 2018-04-10 | The Trustess Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
EP3495357B1 (en) | 2013-03-14 | 2021-05-05 | The Trustees of Columbia University in the City of New York | 4-phenylpiperidines, their preparation and use |
EP3461827B1 (en) | 2013-09-26 | 2022-02-23 | Cadent Therapeutics, Inc. | Selective octahydro-cyclopenta[c]pyrrole negative modulators of nr2b |
AU2015253232B2 (en) | 2014-04-30 | 2020-10-01 | The Trustees Of Columbia University In The City Of New York | Substituted 4-phenylpiperidines, their preparation and use |
JO3579B1 (ar) | 2014-09-26 | 2020-07-05 | Luc Therapeutics Inc | مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول |
CA2992820C (en) | 2015-08-05 | 2022-08-16 | Indivior Uk Limited | Dopamine d3 receptor antagonists having a bicyclo moiety |
WO2018021447A1 (ja) * | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
TW201938537A (zh) | 2018-01-26 | 2019-10-01 | 日商鹽野義製藥股份有限公司 | 具有多巴胺d3受體拮抗作用的稠環化合物 |
CA3090385A1 (en) | 2018-02-05 | 2019-08-08 | Alkermes, Inc. | Compounds for the treatment of pain |
KR20210091726A (ko) | 2018-11-14 | 2021-07-22 | 얀센 파마슈티카 엔.브이. | 오렉신 수용체 조절제로서의 융합 헤테로사이클릭 화합물을 제조하는 개선된 합성 방법 |
MX2021014441A (es) | 2019-05-31 | 2022-01-06 | Ikena Oncology Inc | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. |
AU2020282757A1 (en) | 2019-05-31 | 2021-12-23 | Ikena Oncology, Inc. | TEAD inhibitors and uses thereof |
CN114957087A (zh) * | 2022-04-13 | 2022-08-30 | 湖南复瑞生物医药技术有限责任公司 | 一种帕罗韦德中间体制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL110185C (fi) * | 1958-04-22 | |||
NO154582C (no) * | 1978-10-20 | 1986-11-05 | Ferrosan Ab | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
DE3571436D1 (en) * | 1984-12-21 | 1989-08-17 | Duphar Int Res | New pharmaceutical compositions having anti-psychotic properties |
US4994460A (en) * | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
US5055470A (en) * | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
DE4112353A1 (de) * | 1991-04-16 | 1992-10-22 | Basf Ag | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung |
US5532243A (en) * | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
US5216018A (en) * | 1992-02-14 | 1993-06-01 | Du Pont Merck Pharmaceutical Company | Hydroisoindolines and hydroisoquinolines as psychotropic |
DE4243287A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE4219973A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
-
1993
- 1993-12-04 DE DE4341403A patent/DE4341403A1/de not_active Withdrawn
-
1994
- 1994-11-26 WO PCT/EP1994/003913 patent/WO1995015327A1/en active IP Right Grant
- 1994-11-26 US US08/656,240 patent/US5703091A/en not_active Expired - Lifetime
- 1994-11-26 JP JP51538295A patent/JP3935201B2/ja not_active Expired - Fee Related
- 1994-11-26 EP EP95903284A patent/EP0731802B1/en not_active Expired - Lifetime
- 1994-11-26 DE DE69425273T patent/DE69425273T2/de not_active Expired - Lifetime
- 1994-11-26 AU AU12403/95A patent/AU680583B2/en not_active Ceased
- 1994-11-26 ES ES95903284T patent/ES2148476T3/es not_active Expired - Lifetime
- 1994-11-26 AT AT95903284T patent/ATE194620T1/de active
- 1994-11-26 BR BR9408246A patent/BR9408246A/pt not_active Application Discontinuation
- 1994-12-02 IL IL11186194A patent/IL111861A/xx not_active IP Right Cessation
- 1994-12-05 TW TW083111264A patent/TW285667B/zh active
-
1996
- 1996-06-03 FI FI962324A patent/FI113644B/fi not_active IP Right Cessation
- 1996-06-03 NO NO962286A patent/NO306346B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI113644B (fi) | 2004-05-31 |
WO1995015327A1 (en) | 1995-06-08 |
AU680583B2 (en) | 1997-07-31 |
TW285667B (fi) | 1996-09-11 |
EP0731802B1 (en) | 2000-07-12 |
BR9408246A (pt) | 1997-05-27 |
IL111861A0 (en) | 1995-03-15 |
AU1240395A (en) | 1995-06-19 |
JPH09506346A (ja) | 1997-06-24 |
EP0731802A1 (en) | 1996-09-18 |
IL111861A (en) | 1999-08-17 |
FI962324A (fi) | 1996-06-03 |
JP3935201B2 (ja) | 2007-06-20 |
ES2148476T3 (es) | 2000-10-16 |
NO306346B1 (no) | 1999-10-25 |
DE69425273D1 (de) | 2000-08-17 |
NO962286L (no) | 1996-06-03 |
DE69425273T2 (de) | 2001-01-18 |
US5703091A (en) | 1997-12-30 |
ATE194620T1 (de) | 2000-07-15 |
NO962286D0 (no) | 1996-06-03 |
DE4341403A1 (de) | 1995-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI962324A0 (fi) | N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
DE69413542D1 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
DK0712396T3 (da) | Substituerede azadioxacycloalkener og deres anvendelse som fungicider | |
AU3563695A (en) | Novel piperidine derivatives with paf antagonist activity | |
NO962285D0 (no) | N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika | |
DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
NO970474L (no) | N-substituerte azabicykloheptan-derivater egnet som neuroleptika | |
DK0731801T3 (da) | Substituerede aminoaylkylaminopyridiner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |